MVCAX | VVOAX | MVCAX / VVOAX | |
Total Expense Ratio | 0.99 | 1.07 | 93% |
Annual Report Gross Expense Ratio | 1.00 | 1.07 | 93% |
Fund Existence | 24 years | 24 years | - |
Gain YTD | -9.452 | -11.655 | 81% |
Front Load | 6% | 6% | 105% |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.6B | 4.31B | 362% |
Annual Yield % from dividends | 0.90 | 0.41 | 219% |
Returns for 1 year | -8.84 | -1.09 | 812% |
Returns for 3 years | -6.83 | 11.05 | -62% |
Returns for 5 years | 62.18 | 134.80 | 46% |
Returns for 10 years | 43.47 | 33.31 | 131% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
XC | 29.29 | 0.15 | +0.51% |
WisdomTree Emerging Markets ex-China ETF | |||
BBC | 16.48 | 0.08 | +0.49% |
Virtus LifeSci Biotech Clinical Trls ETF | |||
PAAA | 50.94 | 0.11 | +0.22% |
PGIM AAA CLO ETF | |||
BKIE | 75.51 | 0.16 | +0.21% |
BNY Mellon International Equity ETF | |||
SPXT | 86.94 | -0.28 | -0.32% |
ProShares S&P 500® ex-Technology |